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Down syndrome (DS) is an intellectual disability (ID) disorder in which language
and specifically, verbal fluency are strongly impaired domains; nearly all adults show
neuropathology of Alzheimer’s disease (AD), including amyloid deposition by their fifth
decade of life. In the general population, verbal fluency deficits are considered a
strong AD predictor being the semantic verbal fluency task (SVFT) a useful tool for
enhancing early diagnostic. However, there is a lack of information about the association
between the semantic verbal fluency pattern (SVFP) and the biological amyloidosis
markers in DS. In the current study, we used the SVFT in young adults with DS to
characterize their SVFP, assessing total generated words, clustering, and switching. We
then explored its association with early indicators of dementia, adaptive behavior and
amyloidosis biomarkers, using the Dementia Questionnaire for Persons with Intellectual
Disability (DMR), the Adaptive Behavior Assessment System-Second Edition (ABAS-II),
and plasma levels of Aβ peptides (Aβ40 and Aβ42), as a potent biomarker of AD. In
DS, worse performance in SVFT and poorer communication skills were associated with
higher plasma Aβ42 concentrations, a higher DMR score and impaired communication
skills (ABAS–II). The total word production and switching ability in SVFT were good
indicators of plasma Aβ42 concentration. In conclusion, we propose the SVFT as a
good screening test for early detection of dementia and amyloidosis in young adults
with DS.
Keywords: Down syndrome, Alzheimer’s disease, semantic verbal fluency, switching, Aβ, amyloid precursor
protein, communication skills, DMR
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INTRODUCTION
Adults with Down syndrome (DS) have a high risk for
the development of early onset dementia and invariably
develop senile plaques, composed of β-amyloid peptide
(Aβ), indistinguishable from the histopathology of sporadic
Alzheimer’s disease (AD; Rumble et al., 1989). Plaques can be
found in almost all adults from 35–40 years of age (Zigman
et al., 2008), and the presence of Aβ oligomers can be detected
as early as during fetal development (Teller et al., 1996; Lott and
Dierssen, 2010), although the clinical symptoms clearly differ
from those observed in AD in general population.
The increase in lifespan in the DS population has made
the early detection of dementia of Alzheimer’s type a major
objective of researchers and clinicians. In the general population
impairments in semantic fluency exist prior to the clinical
diagnosis of AD (Vogel et al., 2005). Specifically, patients with
AD exhibit important deficits in both semantic and phonemic
fluency, being the former the most impaired (Cerhan et al., 2002;
Canning et al., 2004; Henry et al., 2004; Taylor et al., 2005).
Thus, alterations in clustering and switching abilities during
the performance of a semantic verbal fluency task (SVFT) are
considered early predictors of the development of AD in the
general population (Palmer et al., 2003; Fagundo et al., 2008).
Conversely, even though research on DS has substantiated
language and verbal fluency as one of the most impaired
domains (Palmer et al., 2003) influencing cognitive-related
outcomes and daily living functionality (Edgin et al., 2010; de
Sola et al., 2015), there is a paucity of information about the
verbal fluency pattern in DS young adults. To our knowledge,
only two studies have reported the semantic verbal fluency
pattern (SVFP) in DS, one in pediatric population, in which a
reduced productivity of words and switching was shown in DS
subjects compared to age-matched controls (Nash and Snowling,
2008) suggesting less efficient retrieval strategies. The second
one in adult population with learning disabilities (Rowe et al.,
2006), showed reduced word production, but the responses were
only analyzed accounting for total number of correct words,
regardless of performance in retrieval strategies such as clustering
and switching.
To date AD conversion in aged DS subjects is mainly analyzed
by measuring plasma Aβ concentrations. Several studies have
shown increased concentrations of both Aβ40 and Aβ42 in young
DS compared to control population (Mehta et al., 2003; Head
et al., 2011) and most found higher concentrations of Aβ42 in
those DS individuals that were either demented or developed
dementia at follow-up (Schupf et al., 2007; Prasher et al., 2010;
Coppus et al., 2012). Some correlations have also been found
between high Aβ40 plasma levels and dementia status, and
between increases in Aβ40 and decreases of Aβ42 and risk of
dementia (Schupf et al., 2007, 2010; Head et al., 2011; Coppus
et al., 2012). Interestingly, most studies report no correlation
between age and Aβ42 levels (Prasher et al., 2010; Head et al.,
2011).
In the current study, we aimed at characterizing the SVFP
including clustering and switching abilities in adults with DS
in comparison to age-matched general population. To this aim,
we used the SVFT that requires verbal abilities, search and
retrieval skills, adequate processing speed, and the capacity to
inhibit inappropriate responses (Henry and Phillips, 2006). The
total number of words and the clustering, which measures the
way these words are grouped by different semantic categories
(i.e., pets, farm, aquatic animal etc.), provide an indirect measure
of the organization of semantic representations. On the other
hand, the use of retrieval strategies, such as switching from
one semantic category group of words to a new one, yields
information about the set shifting ability, an executive skill
related to the integrity of the frontal lobes. We then explored
the association of SVFT performance with early indicators of
dementia, adaptive behavior and amyloidosis biomarkers (Aβ40
and Aβ42).
MATERIALS AND METHODS
Participants
The sample was drawn from the baseline visit of a clinical trial
(TESDAD Study ClinicalTrials.gov Identifier: NCT01699711).
Participants enrolled in our cross-sectional study (n = 50) were
young adults (aged 17–34 years) of both genders with DS
(complete trisomy 21, mosaic or translocation). Subjects with
neurological disease other than DS (epilepsy, cerebral palsy,
hemiplegia, central nervous system infection with neurological
deficit), relevant medical disease, unstable co-morbid mental
disorder (anxiety disorder, depression, obsessive compulsive
disorder), or undergoing any treatment that could interfere
with cognitive function or alter key biomarker analyzed were
excluded from the study. Also, exclusion criteria included
subjects with severe language deficit (significant speech and/or
comprehension limitations), behavioral disturbances and/or
poor level of collaboration during the assessment but no subjects
were excluded from the analysis by this criterion.
To determine the gap in cognitive performance between
DS subjects and healthy adults a comparison group, matched
for age (mean age: 22.6 ± 3.8) was included 59 young
healthy adults of both genders. These participants were assessed
in previous neuropsychological studies (de Sola et al., 2008;
Fagundo et al., 2010). Healthy volunteers were excluded if they
had neurological or relevant medical diseases, or if they had
been diagnosed with a psychiatric disorder following DSM-IV
criteria. Whilst prevailing methodology compares DS subjects
to healthy controls of the same ‘‘mental age’’ to provide an
index of global level of mental functioning (Edgin et al., 2010;
Finestack and Abbeduto, 2010), this perspective is not useful for
characterizing specific capacities (Costanzo et al., 2013; de Sola
et al., 2015).
The study was conducted in accordance with the Declaration
of Helsinki and Spanish laws concerning data privacy. The
protocol was approved by the Ethical Committee of the Parc
de Salut Mar of Barcelona (CEIC-PSMAR). Upon arrival at the
research center (Hospital del Mar Medical Research Institute-
IMIM), participants, parents and legal guardians (in case of legal
incapacitation) were informed of the ensuing protocol and they
gave their written informed consent before participating.
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Procedure
Semantic Verbal Fluency Pattern
We used the SVFT (Benton et al., 1976) as a measure of semantic
memory and executive functioning. Three outcome variables
were obtained: (i) the total number of correctly generated
words in 60 s, and the percentage of words generated every
15 s; (ii) errors committed including intrusions (words not
belonging to the specified semantic category), perseverations
and repetitions (same words or same words with different
endings); and (iii) clustering and switching measures that
were obtained to determine the strategies used to perform
the task. Mean cluster size was the main dependent variable
for clustering, whereas number of switches was the main
dependent variable for switching (Troyer et al., 1997; Troyer,
2000). A cluster was defined as any series of two or more
successively produced words belonging to the same semantic
subcategory, determined a priori (Fagundo et al., 2010). Cluster
size was computed by adding up series of words from the same
subcategory starting from the second word within each cluster
(i.e., a three-word cluster has a size of two). The number of
switches was defined and computed as the number of times
the participant changed from one cluster to another. Two
clusters may also be overlapping, for example, from ‘‘farm
animals’’ to ‘‘birds’’ in ‘‘cow–pig–chicken–pigeon–eagle.’’ Here,
one switch is made between the cluster ‘‘cow–pig–chicken’’
and ‘‘chicken–pigeon–eagle.’’ The computation of number of
switches included single-word clusters. An inter-rater reliability
analysis was performed and the reliability studied by means of
the intra-class correlation coefficient (ICC) was high with values
ranging from 0.89–0.98.
Intellectual Quotient IQ
The intellectual quotient estimation was assessed with The
Kaufman Brief Intelligence Test (Kaufman and Kaufman, 1990).
Functional Measures
The Adaptive Behavior Assessment System-Second Edition
(ABAS-II, adult version; Harrison and Oakland, 2003) for
evaluating adaptive skills in people with intellectual disabilities
and the Dementia Questionnaire for Persons with Intellectual
Disability (Evenhuis et al., 2006) previously named Dementia
Questionnaire for persons with Mental retardation. The DMR
is a self-reported questionnaire about daily living abilities,
which measures specific memory and orientation cognitive skills
and social deterioration as a result of dementia and/or severe
sensory or psychiatric problems. It consists of 50 items and
eight subscales. Combined scores on the first three subscales
(Short-term memory, Long-term memory and Orientation) are
presented as the Sum of Cognitive Scores (SCS). Combined
scores on subscales four through to eight (Speech, Practical skills,
Mood, Activity and Interest, and Behavioral disturbance) are
presented as the Sum of Social Scores (SOS). Higher scores in
DMR reflect a worse state, while higher punctuations in ABAS-II
reflect a better adaptive behavior.
Both questionnaires were given to the caregivers for
completion while participants completed the neuropsychological
testing. We ensured they understood how to complete the
questionnaires and solved all doubts before and after completion,
and checked that all questions were filled.
Plasma Aβ Measurement
Overnight fasting blood samples were collected on site by a
qualified nurse, during the morning hours. The blood was drawn
into 8 mL Heparin Lithium tubes (B&D, UK), centrifuged at
4◦C for 15 min at 3000 rpm, and the plasma was distributed in
aliquots and stored at −70◦C until analysis. Samples (only for
DS subjects) were analyzed for plasma Aβ concentrations, using
Inno-bia Plasma Aβ forms (Aβ40 and Aβ42, truncated Aβ40 and
Aβ42 not reported) assay (Innogenetics, Fujirebio) following the
manufacturer instructions. The plaques were read in a Bio-Plex
200 Systems (Bio-Rad) instrument, and the standard curves were
fitted using the provided software (Bioplex Manager 6.1).
Statistical Analysis
Results are described by means of measures of both central
tendency (mean and median) and variability (standard deviation
and range) for numeric variables, and absolute and relative
frequencies for categorical variables. In the case of the IQ, only
the median is reported because no distinction is made of values
below 40. The differences between DS and healthy groups with
respect to semantic verbal fluency performance are quantified
by means of the standardized mean difference (Cohen’s d).
The computation of all correlations of interest was done using
Pearson’s correlation coefficient. ANCOVA models were used
to study the associations in DS between semantic verbal fluency
outcomes, other cognitive and functional measures, and AD
biomarkers, on one hand, and gender, IQ, and age, on the other
hand. For these analyses, the IQ was categorized into two groups:
mild/moderate (IQ ≥ 40) and severe (IQ < 40) within the range
of ID level.
Statistical significance was set at 0.05. All statistical analyses
were performed using the statistical software packages SPSS
(Version 18.0; SPSS Inc., Chicago, IL, USA) and R (Version 3.2.1;
The R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Descriptive Demographic and Clinical Data
of the Participants
In our DS sample, 48% individuals were male and the mean age
was 23.6 years (standard deviation (SD): 4.5 years; range: 17–34
years). The median IQ was 41 (38% with IQ less than 40) and a
maximum IQ of 70, whereas the mean K-BIT standardized score
was 103 (SD: 14.9; range: 80–151). In terms of gender, themedian
IQ among males was 40 (IQ less than 40: 37.5%; maximum: 66)
and among females 41.5 (IQ less than 40: 38.5%; maximum: 70),
whereas the mean K-BIT standardized scores were 101 (SD: 15.6;
range: 80–144) and 105 (SD: 14.3; range: 80–151), respectively.
Concerning the DS karyotypes, the sample showed the usual
proportion for this population, with most individuals with full
trisomy 21 (48 simple trisomies, one translocation, and one
mosaic). Regarding Aβ plasma concentrations, the mean Aβ40
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concentration was 270.9 pg/mL [SD: 50.8; range: 174–439.3] and
the mean Aβ42 was 41 pg/mL [SD: 10; range: 21.5–60.9].
Semantic Verbal Fluency Performance in
DS Individuals Compared to Standard
Norms
Descriptive analyses, Cohen effect size differences (d), and
confidence intervals (95% CI) of fluency task performance in DS
individuals and age-matched standard norms are summarized
in Table 1. Our results show that in DS switching correlated
more strongly than clustering with the total number of words
generated (See Table 2). We found no correlation between the
percentage of words produced in the first 15 and last 45 s, with the
total number of words. The mean percentage of words produced
in the first 15 s was 37.8%.
On the contrary, in age-matched healthy population there is a
stronger correlation between clustering and the total number of
generated words, while there is no correlation between switching
and the total number of words produced. Besides, we found a
negative correlation between the percentage of words produced
in the first 15 s (mean percentage = 39.6) and the total number
of words, and a positive correlation between the percentage of
words produced during the last 45 s and the total number of
words, indicating a more extensive lexicon in this population.
Association between IQ, Gender and
Age, and Semantic Verbal Fluency
Outcomes in DS
ANCOVA models were applied to analyze the association
between the IQ, gender, and age and the semantic verbal
fluency performance of DS individuals. As shown in Table 3, no
statistically significant associations were found between IQ, age
and gender, and the verbal fluency pattern in the DS group.
Association between IQ, Gender, and Age
and AD Biomarkers in DS
ANCOVA models were applied to analyze the association
between IQ, gender, and age, on one hand, and Aβ40, Aβ42,
Aβ42/40 plasma concentrations of DS individuals, on the other
hand. We found a statistically significant association between IQ
and Aβ40. The negative parameter estimate indicates lower Aβ40
concentrations among DS individuals of the same age and sex
with an IQ< 40 compared with those with an IQ≥ 40 (Table 4).
Associations of Aβ42 Concentration with
Cognitive and Dementia Rating Functional
Outcomes
ANCOVA models were applied to analyze the association
between Aβ42 concentration and both semantic verbal fluency
outcomes and functional state among DS individuals. The
models were adjusted for IQ, sex, and age (Table 5). Individuals
with higher concentrations of Aβ42 produced lower number of
correct words and lower number of switches. Regarding adaptive
behavior, subjects with higher Aβ42 plasma concentrations had
lower scores in the subscale ‘‘Communication skills’’ of the ABAS
questionnaire. Concerning dementia rating, higher Aβ42 plasma
concentrations were associated with higher DMR total score;
see Figure 1 for graphical representations of the statistically
significant associations.
Correlation between Fluency Measures
and Functional Outcomes
The total number of words produced in 1 min and switching
have both a positive correlation with communication skills and a
negative correlation with the DMR total score. Furthermore, the
total number of words produced in 1 min is positively correlated
with the ABAS total score (Table 6).
DISCUSSION
Our study has found an association between the SVFP, dementia
rates, and adaptive behavior related to communication skills in
young adults with DS. Moreover, worse semantic fluency, higher
dementia rates, and poor adaptive behavior and communication
skills were associated to higher plasma concentrations of an AD
biomarker (Aβ42).
The observed associations between cognitive, functional, and
biological parameters suggest that SVF assessment could be
used a screening test for early detection of early symptoms of
dementia DS. Furthermore, our study shows for the first time
TABLE 1 | Cognitive performance in DS individuals compared to standard norms.
Down syndrome Reference standard norms Standardized mean differences
Verbal fluency Mean (SD) Range (min–max) Mean (SD) Range (min–max) d 95%-CI
Number of correct words in 60’ 9.4 (4.1) 1–20 25.1 (5.7) 11–38 −3.13 [−3.69, −2.57]
Percentage of correct words 0–15’ 39.2 (16.6) 0–100 39.6 (7.9) 25–54 −0.03 [−0.46, 0.4]
Percentage of correct words 16–30 28.1 (12.3) 0–50 22.7 (6.5) 14–39 0.53 [0.09, 0.96]
Percentage of correct words 31–45 16.4 (12.4) 0–50 18.6 (5.8) 5–32 −0.22 [−0.65, 0.21]
Percentage of correct words 46–60 17.1 (12.0) 0–60 18.6 (9.5) 0–46 −0.14 [−0.56, 0.29]
Number of switches 4.3 (2.5) 0–13 7.4 (2.1) 3–11 −1.4 [−1.82, −0.97]
Mean cluster size 1.1 (0.8) 0–3.3 2.8 (0.9) 1.4–6.6 −1.93 [−2.39, −1.46]
The standardized mean differences are calculated using Cohen’s d. Age range: DS: 17–34, Reference standard norms 18–33 Sample size: DS: n = 51, Reference
Standard norm: n = 59.
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TABLE 2 | Correlation between fluency strategies and the total number of words produced (Pearson’s correlation coefficient).
Total correct words
Down syndrome Reference standard norms
Correlation [95%-CI] p-value Correlation [95%-CI] p-value
Number of switches 0.73 [0.57, 0.84] <0.001 0.17 [−0.1, 0.41] 0.244
Mean cluster size 0.3 [0.02, 0.53] 0.039 0.49 [0.26, 0.67] <0.001
Percentage of animals in the first 15 s 0.03 [−0.25, 0.31] 0.84 −0.54 [−0.73, −0.25] 0.001
Percentage of animals in the last 45 s 0.11 [−0.18, 0.38] 0.453 0.51 [0.22, 0.72] 0.001
clear differences in the SVFP of a DS young adult population
compared to healthy age-matched individuals.
Fluency Deficits in Young Down Syndrome
Adults
Impairment of verbal fluency, as estimated by lexical knowledge,
is a feature of DS (Rowe et al., 2006). Our results showed
a reduction of switching and cluster size as compared to
the age-matched group, possibly due to a worse semantic
knowledge. This profile is similar to the so called dysexecutive
syndrome, described as a common pattern of dysfunction
in executive functions such as planning, abstract thinking,
flexibility, and behavioral control (Wilson et al., 1998).
A dysexecutive syndrome has already been reported in DS
(Rowe et al., 2006; Lanfranchi et al., 2010; de Sola et al.,
2015), and has been related to the reduced volume of
the prefrontal cortex reported in neuroimaging studies (Raz
et al., 1995; White et al., 2003; Carducci et al., 2013),
in particular affecting the anterior cingulate gyrus, medial,
and dorsolateral prefrontal cortices (Contestabile et al., 2010;
Lott and Dierssen, 2010). These areas actively contribute
to mnemonic processing and executive control in euploid
individuals (Braver et al., 2001; Wager and Smith, 2003;
Blumenfeld et al., 2011), and, thus, the generalized impairment of
high order frontal-dependent processes has a negative influence
on SVFP which depends on both mnemonic and executive
processes.
Similarly to what is observed in healthy population in our
DS group the word production decreases significantly with time,
although in the DS group we detected the wide individual
variability typically shown in the DS population. The production
decrease over time can be explained according to the model
of lexical organization (Crowe, 1996), which states that there
are two types of storages, namely: (1) a long-term storage
(‘‘topicon’’) which is readily accessible and contains common
words and (2) a more extensive lexicon which is searched after
the ‘‘topicon’’ is exhausted. Thus, successful performance on a
verbal fluency task seems to be subjected to the effectiveness of
both automatic and controlled processing (Crowe, 1998; Hurks
et al., 2006). In our DS sample, subjects are not differentiating
between using automatic processing and instead, they access to
the pool of frequently used words, but when this is exhausted,
they fail in using controlled attentional searching retrieval
processes that involve executive strategies with high impact on
total word production, such as switching. Word production in
normative age matched population also decreases over time,
paired with a high percentage of words produced in the first
15 s as reported in previous studies (Villodre et al., 2006).
However, their topicon and lexicon are richer than DS due to
better semantic knowledge (clustering) and retrieval strategies
(switching).
Aβ Plasma Concentrations in Young DS
Group
Regarding the plasma concentrations of amyloid peptides, few
studies have measured the concentrations of such biomarkers in
young adults (Mehta et al., 2003; Head et al., 2011), and those
were performed in older populations. Compared to them, we
obtained higher mean concentrations of Aβ42 (41 ± 10 pg/mL),
possibly due to the sensitivity of method we used. However,
another study performed in younger DS subjects (mean 7.2 ±
3.8) obtained concentrations (31.6± 8.2 pg/mL) that were closer
to our mean values (Mehta et al., 2007).
Contrary to previous studies in older DS populations (Prasher
et al., 2010; Schupf et al., 2010; Head et al., 2011) that report a
correlation of Aβ42 with age, in ours this is not present suggesting
that factors other than age are affecting the Aβ42 production.
In light of our results, the impact of these biomarkers and their
evolution pattern should be studied throughout adulthood in DS,
and not only in the elderly.
TABLE 3 | Association between the verbal fluency pattern and the intellectual quotient (IQ), sex and age in DS individuals.
IQ (<40 vs. ≥40) Sex (Women vs. men) Age
Verbal fluency outcomes Estimate (SE) p Estimate (SE) p Estimate (SE) p
Number of correct words in 60 s −1.04 (1.18) 0.386 0.45 (1.17) 0.704 0.18 (0.13) 0.190
Number of switches 0.25 (0.73) 0.736 0.44 (0.72) 0.547 0.04 (0.08) 0.663
Mean cluster size −0.36 (0.23) 0.112 −0.07 (0.22) 0.750 0.02 (0.03) 0.488
Parameter estimates, standard errors (SE), and p-values are obtained from ANCOVA models.
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TABLE 4 | Association between Aβ concentrations and intellectual quotient (IQ), sex, and age in DS individuals.
IQ (<40 vs. ≥40) Sex (Women vs. men) Age
Aβ concentrations Estimate (SE) p Estimate (SE) p Estimate (SE) p
Aβ42 −2.05 (2.97) 0.495 2.12 (2.94) 0.475 −0.21 (0.33) 0.527
Aβ40 −38.2 (14.6) 0.012 19.9 (14.2) 0.167 −0.26 (1.59) 0.873
Aβ40/42 0.007 (0.013) 0.564 0.004 (0.012) 0.758 −0.0002 (0.001) 0.893
Parameter estimates, standard errors (SE), and p-values are obtained from ANCOVA models.
TABLE 5 | Association between Aβ42 concentration and cognitive and
functional measure.
Estimate (SE) p
Cognitive performance in SVFT
Number of correct words in 60’ −0.187 (0.052) <0.001
Number of switches −0.085 (0.035) 0.018
Mean cluster size −0.006 (0.011) 0.582
Functional outcomes
ABAS adaptive behavior: communication skills −0.532 (0.158) 0.001
DMR total score 0.366 (0.113) 0.002
Parameter estimates, standard errors (SE), and p-values are obtained from
ANCOVA models adjusted for IQ, age, and sex.
Association between Fluency Performance
and Aβ Concentrations
A large subset of aged individuals with DS develop clinical
features of AD and some studies have suggested deficits in
executive function (Holland et al., 2000; Ball et al., 2006).
In AD patients, AD was better predicted by the clustering
ability in some reports (Fagundo et al., 2008), although
others (Raoux et al., 2008) found a significant decline in
switching along the early phase until the clinical diagnosis
of AD dementia. In our DS population, switching and the
total number of words are the verbal fluency markers that
better correlate with the plasma Aβ42 concentrations. This
observation supports the hypothesis that impaired switching
abilities could explain the early decline in semantic fluency
performance in an early state of AD. Moreover, the association
between AD biomarkers and verbal fluency pattern is supported
by the correlation that we found between Aβ concentrations,
dementia ratings (DMR), and communication skills. We
observed that higher concentrations of Aβ42 were associated to
lower adaptive behavior and communication skills and higher
DMR scores. In accordance, DMR can be considered useful
detecting early symptoms of AD in DS. These results would
also be in agreement with previous studies linking higher
Aβ42 plasma concentrations in elderly DS with dementia or
the development of dementia (Schupf et al., 2007; Prasher
et al., 2010; Coppus et al., 2012). Furthermore, DMR scores
were inversely correlated with the SVFP. This is interesting
because, in our study, positive correlations were found between
communication skills, semantic verbal fluency, and switching,
as discussed above. Communication abilities are a compilation
of cognitive and social processes such as comprehension,
expression, and empathy. Semantic verbal fluency seems to
be part of this compilation of abilities involved in verbal
expression as forming part of communication skills. In our
case, the DS subjects are not demented, but there is a
clear correlation between higher Aβ42 and worse scores in
functional variables that can be used to detect an early dementia
state.
Limitations
The present study has several limitations. First, plasma
measurements of Aβ concentrations remain controversial. Their
high variability and lack of correlation with the observations of
amyloidosis in the brain are some of the reasons leading some
researchers to perform their measurements in CSF, that were
not performed in our study. In our study, several peripheral
tissues and cells, such as muscle and platelets, could be the
source of peripheral Aβ (Toledo et al., 2014). However, in the
context of clinical trials, as well as in clinical practice in general,
it is worth improving the reliability of this blood measurement,
as it is much less invasive than CSF extraction, as well as
exploring its correlations with early cognitive symptoms of AD.
Second, we only compared the SVFT between the DS group and
the age-matched group. The rest of assessments as dementia
rates, adaptive behavior and Aβ concentrations are lacking
a comparative group. Finally, the high number of statistical
tests carried out may increase the probability of Type-1 errors.
Nonetheless, no correction to control a family-wise significance
level of 0.05 has been applied in order not to increase the
probability of Type-2 errors.
TABLE 6 | Correlation between cognitive and functional variables measured using Pearson’s correlation coefficient.
DMR total ABAS total ABAS communication skills
Correlation [95%-CI] p-value Correlation [95%-CI] p-value Correlation [95%-CI] p-value
Number of correct words in 60’ −0.5 [−0.68, −0.25] <0.001 0.32 [0.05, 0.55] 0.024 0.45 [0.2, 0.65] 0.001
Number of switches −0.39 [−0.6, −0.12] 0.006 0.21 [−0.07, 0.46] 0.144 0.28 [0.01, 0.52] 0.046
Mean cluster size −0.14 [−0.41, 0.14] 0.328 0.13 [−0.15, 0.4] 0.36 0.22 [−0.06, 0.47] 0.127
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FIGURE 1 | Verbal fluency and functional measures as a function of Aβ42 concentration. Correlations are shown for Aβ42 and Upper panel: number of
correct words (left) and number of switches (right). Lower panel: ABAS adaptive behavior (left) and DMR total score (right). The figures include the regression lines
from the corresponding linear regression models.
CONCLUSION
Several studies have sought to understand the implications
of changes in plasma Aβ concentrations with regard to the
development of AD in DS using Mini Mental State Evaluation
(MMSE), yet none has looked at the correlations between
changes in concentrations and changes SVFP. Our results show
an association between SVFP and early AD symptoms and
plasma Aβ concentrations supporting the use of SVFT as a useful
tool to detect DS subjects who are vulnerable to develop early
onset AD.
Our results may be taken as a first step for further studies to
find easy and fast non-invasive tools to predict the early onset of
AD in DS population.
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